About: Positive result of Sars‐Cov‐2 in faeces and sputum from discharged patient with COVID‐19 in Yiwu, China

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Positive result of Sars‐Cov‐2 in faeces and sputum from discharged patient with COVID‐19 in Yiwu, China Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Positive result of Sars‐Cov‐2 in faeces and sputum from discharged patient with COVID‐19 in Yiwu, China
Creator	Wu, Jianguo Li, Bin Yu, Yuanyuan Li, Junyu Xu, Jian Zhang, Xiaodong Hu, Yingying Wu, Yingping Xia, Xiaoping Li, Youjiang Tang, Huina
source	Medline; PMC
abstract	BACKGROUND: With the effective prevention and control of COVID ‐ 19 in China, the number of cured cases increased significantly. Further monitoring of the disease prognosis and effective control of the %22relapse%22 of the epidemic become the next focus of work. To analyse the clinical prognosis of discharged COVID‐19 patients by monitoring their SAR‐CoV‐2 nucleic acid status, which may provide evidence to establish discharge standards and follow‐up management for COVID‐19 patients. METHODS: We included 13 discharged COVID‐19 patients who were quarantined for 4‐week at home. The patient's daily clinical signs were recorded and sputum and faecal specimens were regularly sent for the detection of SARS‐CoV‐2 nucleic acid. RESULTS: The time between initial symptoms and meeting discharge criteria was 18 – 44 days with an average of 25 ± 6 days. The faecal samples of two patients still tested positive after meeting discharge criteria and the sputum samples of four patients returned positive 5 – 14 days after discharge. The rate of a recurring positive test result in samples from the respiratory system was 31%(4/13). CONCLUSION: Under the present discharge criteria, the high presence of SARS‐CoV‐2 nucleic acid in faecal and respiratory samples of discharged COVID‐19 patients indicate potential infectivity. Therefore, we suggest that faecal virus nucleic acid should be tested as a routine monitoring index for COVID‐19 and a negative result be added to the criteria. Simultaneously, we should strengthen the regular follow‐up of discharged patients with continuous monitoring of the recurrence of viral nucleic acid. This article is protected by copyright. All rights reserved.
has issue date	2020-04-20(xsd:dateTime)
bibo:doi	10.1002/jmv.25905
bibo:pmid	32311109
has license	no-cc
sha1sum (hex)	addb074446a63844092659ec9991771d37b09a38
schema:url	https://doi.org/10.1002/jmv.25905
resource representing a document's title	Positive result of Sars‐Cov‐2 in faeces and sputum from discharged patient with COVID‐19 in Yiwu, China
has PubMed Central identifier	PMC7264799
has PubMed identifier	32311109
schema:publication	J Med Virol
resource representing a document's body	covid:addb074446a63844092659ec9991771d37b09a38#body_text
is schema:about of	named entity 'WEEK' named entity 'SENT' named entity 'PATIENTS' named entity 'DAYS' named entity 'CASES' named entity 'ACCEPTED' named entity 'TIME' named entity 'ADDED' named entity 'PROVIDE' named entity 'INCREASED' named entity 'DISCHARGE CRITERIA' named entity 'SAR' named entity 'DETECTION' named entity 'RETURNED' named entity 'NEGATIVE RESULT' named entity 'METHODS' named entity 'RECURRENCE' named entity 'SARS-COV-2' covid:arg/addb074446a63844092659ec9991771d37b09a38 named entity 'COVID' named entity 'nucleic acid' named entity 'positive test' named entity 'infectious diseases' named entity 'protected by copyright' named entity 'prognosis' named entity 'follow-up' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'nucleic acid' named entity 'clinical signs' named entity 'negative result' named entity 'virus' named entity 'Sars-Cov-2' named entity 'COVID-19' named entity 'nucleic acid' named entity 'SARS-CoV-2' named entity 'false negative' named entity 'asymptomatic' named entity 'tested positive' named entity 'faeces' named entity 'viral load' named entity 'pneumonia' named entity 'respiratory droplets' named entity 'respiratory tract' named entity 'Shanghai' named entity 'clinical symptoms' named entity 'CT scans' named entity 'sputum' named entity 'virus' named entity 'nucleic acid' named entity 'digestive tract' named entity 'WHO' named entity 'COVID' named entity 'COVID' named entity 'SPSS' named entity 'infectivity' named entity 'body temperature' named entity 'reverse transcription polymerase chain reaction' named entity 'medical masks' named entity 'SARS-CoV-2' named entity 'virus' named entity 'sputum' named entity 'RT-PCR' named entity 'sputum' named entity 'global pandemic' named entity 'chronic lymphocytic leukemia' named entity 'clinical symptoms' named entity 'SARS-CoV-2' named entity 'Nucleic acid' named entity 'virus' named entity 'SARS-CoV-2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software